Search research articles
Contact Us
Filters
Showing results (161-170 of 170) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 170 results.
Journal of Internal Medicine
|
February 10, 2010
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial
I Holme, R Fayyad, O Faergeman, et al.
Human Mutation
|
January 1, 1997
Two mutations in the same low-density lipoprotein receptor allele act in synergy to reduce receptor function in heterozygous familial hypercholesterolemia
H K Jensen, T G Jensen, O Faergeman, et al.
Circulation
|
May 15, 1996
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study
T R Pedersen, J Kjekshus, K Berg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 1, 1997
Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries
P S Hansen, J C Defesche, J J Kastelein, et al.
Archives of Internal Medicine
|
October 14, 1996
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study
T R Pedersen, K Berg, T J Cook, et al.
The American Journal of Cardiology
|
August 3, 2000
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering
T R Pedersen, L Wilhelmsen, O Faergeman, et al.
Circulation
|
May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
T R Pedersen, A G Olsson, O Faergeman, et al.
Atherosclerosis
|
May 1, 1997
A common W556S mutation in the LDL receptor gene of Danish patients with familial hypercholesterolemia encodes a transport-defective protein
H K Jensen, H Holst, L G Jensen, et al.
Neurologia (Barcelona, Spain)
|
October 8, 2004
[European Guidelines on Cardiovascular Disease Prevention in the Clinical Practice. Third work group of the european societies and other societies on cardiovascular disease prevention in the clinical practice]
G de Backer, E Ambrosioni, K Borch-Johnsen, et al.
Journal of Internal Medicine
|
February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
P J Barter, C M Ballantyne, R Carmena, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 170) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 170 results.
Journal of Internal Medicine
|
February 10, 2010
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial
I Holme, R Fayyad, O Faergeman, et al.
Human Mutation
|
January 1, 1997
Two mutations in the same low-density lipoprotein receptor allele act in synergy to reduce receptor function in heterozygous familial hypercholesterolemia
H K Jensen, T G Jensen, O Faergeman, et al.
Circulation
|
May 15, 1996
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study
T R Pedersen, J Kjekshus, K Berg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 1, 1997
Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries
P S Hansen, J C Defesche, J J Kastelein, et al.
Archives of Internal Medicine
|
October 14, 1996
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study
T R Pedersen, K Berg, T J Cook, et al.
The American Journal of Cardiology
|
August 3, 2000
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering
T R Pedersen, L Wilhelmsen, O Faergeman, et al.
Circulation
|
May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
T R Pedersen, A G Olsson, O Faergeman, et al.
Atherosclerosis
|
May 1, 1997
A common W556S mutation in the LDL receptor gene of Danish patients with familial hypercholesterolemia encodes a transport-defective protein
H K Jensen, H Holst, L G Jensen, et al.
Neurologia (Barcelona, Spain)
|
October 8, 2004
[European Guidelines on Cardiovascular Disease Prevention in the Clinical Practice. Third work group of the european societies and other societies on cardiovascular disease prevention in the clinical practice]
G de Backer, E Ambrosioni, K Borch-Johnsen, et al.
Journal of Internal Medicine
|
February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
P J Barter, C M Ballantyne, R Carmena, et al.
Page
of 17